Zhejiang Yatai Pharmaceutical Co., Ltd. (002370) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Yatai Pharmaceutical Co., Ltd.

Why is Zhejiang Yatai Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of -6.50% and Operating profit at 9.17% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 1.39% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -6.50% and Operating profit at 9.17% over the last 5 years

With a fall in PBT of -111.79%, the company declared Very Negative results in Mar 26

The company has declared negative results for the last 3 consecutive quarters
PRE-TAX PROFIT(Q) At CNY -1.14 MM has Fallen at -104.76%
NET PROFIT(Q) At CNY -0.88 MM has Fallen at -103.7%
OPERATING CASH FLOW(Y) Lowest at CNY 18.41 MM

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zhejiang Yatai Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Yatai Pharmaceutical Co., Ltd.

-9.11%

1.83

61.23%

China Shanghai Composite

3.23%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-6.50%

EBIT Growth (5y)

9.17%

EBIT to Interest (avg)

-1.49

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.46

Sales to Capital Employed (avg)

0.30

Tax Ratio

0.08%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

1.39%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.26

EV to EBIT

-78.30

EV to EBITDA

-190.03

EV to Capital Employed

5.49

EV to Sales

9.69

PEG Ratio

0.14

Dividend Yield

ROCE (Latest)

-7.01%

ROE (Latest)

9.04%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -11.2% (YoY

NET SALES(Q)

Highest at CNY 97.95 MM

OPERATING PROFIT(Q)

Highest at CNY 11.04 MM

OPERATING PROFIT MARGIN(Q)

Highest at 11.27 %

-22What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY -65.71 MM

PRE-TAX PROFIT(Q)

At CNY 7.24 MM has Fallen at -71.33%

NET PROFIT(Q)

At CNY 7.57 MM has Fallen at -70.03%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.07 times

CASH AND EQV(HY)

Lowest at CNY 1,131.9 MM

Here's what is working for Zhejiang Yatai Pharmaceutical Co., Ltd.

Net Sales

Highest at CNY 97.95 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 97.95 MM has Grown at 23.14%

over average net sales of the previous four periods of CNY 79.54 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 11.04 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 11.27 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Raw Material Cost

Fallen by -11.2% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Yatai Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 7.24 MM has Fallen at -71.33%

over average net sales of the previous four periods of CNY 25.27 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 7.57 MM has Fallen at -70.03%

over average net sales of the previous four periods of CNY 25.25 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY -65.71 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debtors Turnover Ratio

Lowest at 2.07 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Cash and Eqv

Lowest at CNY 1,131.9 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Non Operating Income

Highest at CNY 1.86 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income

Footer loading